Why it's time to switch from value to growth stocks
Value stocks have outperformed growth over the past 30 years, research suggests. But it could be time for growth to make a comeback...
According to academic research, says Beth Piskora on BusinessWeek.com, between 1974 and 2005, value stocks have outperformed growth stocks. But the S&P 500/Citigroup Pure Growth and Pure Value indices now hint that the market may be about to enter a period of growth-stock outperformance.
Not only has the momentum been with them over the last four months, but p/e ratios are lower than for value stocks. Hence, S&P's chief investment strategist, Sam Stovall, has "strong buy" recommendations on 18 companies in the Pure Growth index: Capital One (COF, $89.39), Coach (COH, $36.54), Colgate-Palmolive (CL, $54.89), Danaher (DHR, $61.92), Electronic Arts (ERTS, $51.05), Eli Lilly (LLY, $55.74), Home Depot (HD, $42.28), Johnson & Johnson (JNJ, $58.76), Kohl's (KSS, $44.87), Microsoft (MSFT, $26.71), Mylan Labs (MYL, $23.39), Nabors Industries (NBR, $67.99), PepsiCo (PEP, $59.47), Procter & Gamble (PG, $61.94), UnitedHealth Group (UNH, $59.57), Valero Energy (VLO, $54.88), Wal-Mart (WMT, $45.91) and Wrigley (WWY, $64.20).
Out of a further ten growth stocks tipped by Morningstar.com and Kiplinger.com, the most popular is Fastenal (FAST, $43.39), which makes and sells more than 250,000 kinds of fastener, has a total product line of "more than 500,000 items" and runs 1,800 stores. Its stock trades at 32 times estimated earnings per shares of $1.36 for this year, so Fastenal is "pricey". But the company estimates that "there is room in the US and Canada for least 2,500 stores".
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
There is also potential for overseas expansion, and a recent store-remodelling programme "raised sales per employee by more than 30%". As a result, Jeffrey Germanotta of investment bank William Blair thinks that Fastenal "is well positioned to deliver 25% yearly earnings gains over the next few years", putting the company on a price/earnings to growth ratio (see page 46) of 1.28 (1.53 in the opinion of Yahoo).
The other nine growth stocks that "pass muster", according to Kiplinger's and Morningstar, are Strayer Education (STRA, $99.84), 3M (MMM, $74.05), Sysco (SYY, $30.27), International Game Technology (IGT, $36.04), Adobe (ADBE, $39.19), WellPoint (WLP, $77.96), Harman International Industries (HAR, $108.04), Carnival Cruise Lines (CCL, $51.67) and Walgreen (WAG, $46.18).
Sign up for MoneyWeek's newsletters
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
Charles has previously written for the MoneyWeek, giving readers his share tips regularly and covering other topics on the side such as stock markets and the economy. He has also written for The Business, Shares, Investors Chronicle and The Evening Standard, and Charles has presented on LBC and been a guest on BBC One and BBC World. Aside from his journalist background, Charles graduated as a chemist from the University of Oxford specialising in ligand gated ion channels.
-
Spot the Dog: £67bn in underperforming funds revealed
Around 137 funds consistently underperformed their benchmark, BestInvest's Spot the Dog report finds. Which funds are in the dog house?
By Katie Williams Published
-
What does a BP and Shell merger mean for the UK oil industry?
BP’s struggles have made it vulnerable to a takeover. Could it merge with Shell to create a British behemoth?
By Dr Matthew Partridge Published